A study published in the New England Journal of Medicine found that patients across the board seem to heal as much as four days faster after treatment with the drug versus a placebo group. It would also increase the chance of survival.
But the researchers also note that the differences would not be statistically significant. That would mean that it is not clear whether the drug really works. “Given the high mortality despite the use of remdesivir, it is clear that treatment with an antiviral alone will not be sufficient,” the scientists conclude.
The American drug dog FDA previously gave accelerated approval for the use of remdesivir to treat seriously ill corona patients. This also happened recently in Japan. Still, there are still several studies into how effective the drug actually is in the treatment of Covid-19.
Every morning the latest financial news in your inbox?
Invalid email address. Please enter again.
You can unsubscribe with 1 click